Tower Research Capital (TRC)’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2K | Buy |
3,895
+2,703
| +227% | +$18.2K | ﹤0.01% | 3517 |
|
|
2025
Q1 | $10.8K | Sell |
1,192
-354
| -23% | -$3.2K | ﹤0.01% | 3608 |
|
|
2024
Q4 | $26.7K | Sell |
1,546
-4,818
| -76% | -$83.3K | ﹤0.01% | 2971 |
|
|
2024
Q3 | $102K | Buy |
6,364
+3,484
| +121% | +$55.7K | ﹤0.01% | 2224 |
|
|
2024
Q2 | $41K | Buy |
2,880
+2,445
| +562% | +$34.8K | ﹤0.01% | 3244 |
|
|
2024
Q1 | $6.16K | Sell |
435
-5,345
| -92% | -$75.7K | ﹤0.01% | 4421 |
|
|
2023
Q4 | $87.2K | Buy |
5,780
+4,777
| +476% | +$72.1K | ﹤0.01% | 2747 |
|
|
2023
Q3 | $15.8K | Buy |
1,003
+409
| +69% | +$6.46K | ﹤0.01% | 3590 |
|
|
2023
Q2 | $8.99K | Sell |
594
-698
| -54% | -$10.6K | ﹤0.01% | 4326 |
|
|
2023
Q1 | $19K | Buy |
1,292
+845
| +189% | +$12.4K | ﹤0.01% | 3514 |
|
|
2022
Q4 | $6K | Sell |
447
-2,061
| -82% | -$27.7K | ﹤0.01% | 4774 |
|
|
2022
Q3 | $40K | Buy |
+2,508
| New | +$40K | ﹤0.01% | 3360 |
|
|
2022
Q2 | – | Sell |
-2,485
| Closed | -$23K | – | 6523 |
|
|
2022
Q1 | $23K | Buy |
2,485
+7
| +0.3% | +$65 | ﹤0.01% | 3406 |
|
|
2021
Q4 | $42K | Buy |
+2,478
| New | +$42K | ﹤0.01% | 2909 |
|